Skip to main content
Premium Trial:

Request an Annual Quote

Enzo to Supply GSK with Microarray Reagents

NEW YORK, July 20 (GenomeWeb News) - Enzo Life Sciences, a subsidiary of Enzo Biochem, has signed a supply agreement with GlaxoSmithKline for its RNA/DNA labeling, detection, and amplification technologies and products, Enzo said today.

 

Enzo said that GSK plans to use the reagents for microarray-based gene expression experiments, but a spokesman for the company declined to disclose the specific technologies or patents that were included in the non-exclusive licensing agreement.

 

Financial terms of the agreement were not provided.

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.